|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.28 CNY | -0.90% |
|
+0.42% | -0.08% |
| Capitalization | 2.42TCr 347.7Cr 299.75Cr 279.05Cr 259.78Cr 483.68Cr 32TCr 520.4Cr 3.21TCr 1.27TCr 15TCr 1.3TCr 1.28TCr 55TCr | P/E ratio 2025 * |
-
| P/E ratio 2026 * | - |
|---|---|---|---|---|---|
| Enterprise value | 1.32TCr 189.95Cr 163.76Cr 152.45Cr 141.92Cr 264.24Cr 17TCr 284.3Cr 1.75TCr 691.45Cr 8.22TCr 712.34Cr 697.68Cr 30TCr | EV / Sales 2025 * |
-
| EV / Sales 2026 * | - |
| Free-Float |
37.52% | Yield 2025 * |
-
| Yield 2026 * | - |
More valuation ratios
* Estimated data
More news
| 1 day | -0.90% | ||
| 1 week | +0.42% | ||
| Current month | -0.08% | ||
| 1 month | -1.98% | ||
| 3 months | +4.04% | ||
| 6 months | -4.78% | ||
| Current year | -0.08% |
| 1 week | 25.83 |  | 26.63 |
| 1 month | 25.83 | | 27.03 |
| Current year | 25.83 | | 26.71 |
| 1 year | 24.2 | | 30.39 |
| 3 years | 23.85 | | 45.18 |
| 5 years | 14.37 | | 45.18 |
| 10 years | 14.37 | | 54.97 |
| Manager | Title | Age | Since |
|---|---|---|---|
Fei Cao
CEO | Chief Executive Officer | 43 | 20/12/2019 |
Hong Cun Yan
DFI | Director of Finance/CFO | 58 | 26/09/2022 |
Wei Cao
SEC | Corporate Secretary | 40 | 17/09/2018 |
| Director | Title | Age | Since |
|---|---|---|---|
Qu Rong Huang
BRD | Director/Board Member | 64 | 10/03/2014 |
Fei Cao
BRD | Director/Board Member | 43 | 10/03/2014 |
Xin Chun Zhou
CHM | Chairman | 57 | 08/05/2023 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | -19.71% | 0.42% | 0 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.90% | +0.42% | -6.64% | -7.33% | 347.48Cr | |
| -1.15% | -4.19% | -16.47% | -33.00% | 611.72Cr | |
| -0.20% | -1.64% | -21.78% | +18.53% | 452.89Cr | |
| -1.11% | -4.37% | +50.73% | +47.36% | 438.38Cr | |
| -0.96% | -2.01% | +11.43% | -39.06% | 420.79Cr | |
| -1.31% | -1.70% | +5.91% | +31.79% | 322.67Cr | |
| 0.00% | -0.48% | +7.63% | -21.39% | 249.71Cr | |
| -0.33% | -0.69% | +16.43% | +3.61% | 199.24Cr | |
| -0.52% | -1.60% | -1.27% | +51.85% | 169.24Cr | |
| -0.41% | +2.47% | +13.10% | +60.02% | 169.22Cr | |
| Average | -0.69% | -1.22% | +5.91% | +11.24% | 338.13Cr | |
| Weighted average by Cap. | -0.78% | -1.68% | +4.11% | +4.30% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | - | - |
| Net income | 154.7Cr 22Cr 19Cr 18Cr 17Cr 31Cr 2.01TCr 33Cr 204.95Cr 81Cr 960.86Cr 83Cr 82Cr 3.51TCr | 172.4Cr 25Cr 21Cr 20Cr 18Cr 34Cr 2.24TCr 37Cr 228.4Cr 90Cr 1.07TCr 93Cr 91Cr 3.91TCr |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
5,026
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/26/16 | 26.28 ¥ | -0.90% | 41,54,227 |
| 15/26/15 | 26.52 ¥ | +1.57% | 59,01,602 |
| 14/26/14 | 26.11 ¥ | +0.12% | 50,40,241 |
| 13/26/13 | 26.08 ¥ | 0.00% | 40,53,017 |
| 12/26/12 | 26.08 ¥ | -0.34% | 46,20,183 |
End-of-day quote Shanghai S.E., January 16, 2026
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
26.28
Average target price
-
Annual profits - Rate of surprise
- Stock Market
- Equities
- 600566 Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition